EUROPEAN ASSOCIATION FOR CANCER RESEARCH
EACR202516-19 June 2025 Lisboa
N. Poster
Poster title
Applicant name
Status
 |
|
|
|
| 1-EACR25 | Genomic and single-cell characterization of patient-derived tumor organoid models of head and neck squamous cell carcinoma | young min park |  Received |
 |
|||
| 8-EACR25 | TRIB1 leads to M2 skewing of macrophages in LUSC | Dingyu Lu | Received |
|
|||
| 51-EACR25 | Novel Topoisomerase I (Topo1) inhibitors with a non-Camptothecin core scaffold to overcome resistance to current Topo1-targeted drugs and ADCs | QUN DANG | Received |
|
|||
| 163-EACR25 | Chemotherapeutic Response and Resistance in a 3D MDA-MB 231Triple-Negative Breast Cancer Spheroid Model | Beynon Abrahams | Received |
|
|||
| 165-EACR25 | CT Scan Identified Sarcopenia and MST and AND/ASPEN Malnutrition Guidelines in Gastrointestinal Cancer Patients | Mariah Jackson | Received |
|
|||
| 202-EACR25 | The interplay between melatonin and alpha-synuclein on melanoma biomolecular signatures | Panagiota Filippou | Received |
|
|||
| 205-EACR25 | A clinically interpretable machine learning model using 19 proteins to predict recurrence/metastasis in OSCC patients | Kaiyuan Sun | Received |
|
|||
| 266-EACR25 | Patterns of Bone Marrow Adipogenesis in Response to Chemotherapy | Lauren Kreps | Received |
|
|||
| 277-EACR25 | Small cell lung cancer evades immune surveillance through an ERBB2-dependent mechanism | Lydia Meder | Received |
|
|||
| 278-EACR25 | In Silico Identification of Common Pre-existing Resistance Mechanisms to EGFR Inhibitors in Colorectal Cancer | Carlos Fernandez-Lozano | Received |
|
|||
| 311-EACR25 | Assessment of a Fiber-rich Diet in Post-treatment Breast Cancer Survivors | Mariah Jackson | Received |
|
|||
| 423-EACR25 | Cardiac Remodelling and Incident Cardiovascular Risk in Haematological Cancer Survivors from the UK Biobank | Gracia Andriamiadana | Received |
|
|||
| 426-EACR25 | Deciphering the Breast Cancer Metastasis Transcriptome: A Deep Dive into the Enigmatic Role of Circular RNAs. | Adrian Szczepaniak | Received |
|
|||
| 479-EACR25 | Genomic Profiling of Colloid Carcinoma of the Pancreas | Michele Bevere | Received |
|
|||
| 515-EACR25 | Fuelling the fight: The Impact of a Ketogenic Diet on Chemotherapy-induced DNA damage in Acute Leukemia | Gayathiri Rajakumar | Received |
|
|||
| 611-EACR25 | The Impact of Circulating Malignant Tumour Cells on Tumour Recurrence in Oral Squamous Cell Carcinoma | Abdulrahman Sakeen Alkandari | Received |
|
|||
| 678-EACR25 | Computational identification of pan-cancer multi-omic metabolic signatures as prognostic biomarkers and therapeutic targets | Higor Almeida Cordeiro Nogueira | Received |
|
|||
| 683-EACR25 | Pre-clinical Evidence for Ivacaftor as a Potential Repurposed Therapy for High-Grade Serous Ovarian Cancer and Endometrial Cancer | Dongli Liu | Received |
|
|||
| 717-EACR25 | Tumour Volume Dynamics of Glioblastoma During Radiotherapy on 1.5T Magnetic Resonance Imaging-Linear Accelerator | Sweet Ping Ng | Received |
|
|||
| 738-EACR25 | A Pro-Tumorigenic Cytokine with an Unexpected Anti-Cancer Role: TGF Enhances NK cell Immunotherapy for pancreatic cancer | Giampiero Valenzano | Received |
|
|||
| 796-EACR25 | Investigation of driver genes in cancer-associated copy number alterations identifies B4GALT5 as a glycooncogene | Pranoy Sahu | Received |
|
|||
| 800-EACR25 | Unraveling Inflammation-Related microRNAs in Pleural Mesothelioma: Gene Regulation and Pathway Analysis | Giulia Tonnini | Received |
|
|||
| 854-EACR25 | Restoration of Drug Sensitivity and Apoptosis to Drug-Resistant Oesophageal Cancer Cells by USP18 Knockdown in the Presence of IFN-a or Poly (I:C) | Maria Carey | Received |
|
|||
| 916-EACR25 | Detection of low frequency variants from low input FFPE samples with comprehensive tumor/normal exome sequencing | Anna Babayan | Received |
|
|||
| 974-EACR25 | Tumor-infiltrating immune cell types predicting recurrence-free survival in melanoma patients receiving adjuvant PD-1 inhibitor therapy | Andrea Ladányi | Received |
|
|||
| 985-EACR25 | Machine Learning Algorithms for Prediction of Bone Metastasis Risk in Patients with Lung Cancer | RACHEL SIU KING LUK | Received |
|
|||
| 1001-EACR25 | Pioneer Platform: A Novel Biotherapeutic Antibody Discovery Platform | Paola Genevini | Received |
|
|||
| 1023-EACR25 | Histone deacetylase inhibitors (HDACi) downregulate HER2 protein expression in gastric cancer, leading to pronounced HDACi sensitivity in tumor cells with high basal HER2 expression | Achim Aigner | Received |
|
|||
| 1025-EACR25 | CircRNA-mediated inhibition of miRNA-454 as a novel therapeutic strategy in prostate cancer | Achim Aigner | Received |
|
|||
| 1101-EACR25 | BR55: Clinical Development of the First Ultrasound Molecular Imaging Agent for angiogenesis | Victor Jeannot | Received |
|
|||
| 1156-EACR25 | Redirecting cytomegalovirus immunity against pancreas cancer for immunotherapy | Tatiana Hurtado de Mendoza | Received |
|
|||
| 1175-EACR25 | Unified Whole Genome Sequencing for Hematological Malignancies | Severine Catreux | Received |
|
|||
| 1186-EACR25 | Targeted Treatment of Solid Tumors with BRAF Fusions | Joseph Samuel | Received |
|
|||
| 1212-EACR25 | Predicting Second-Line Chemotherapy Outcome in Advanced Pancreatic Cancer: A Machine Learning Approach Using PBMC-Based Biomarkers - Translational Findings from the PREDICT Trial | Anton Lahusen | Received |
|
|||
| 1225-EACR25 | DTFD-MIL-CN: A Cost-Effective and Accurate Deep Learning Model for Hormone ReceptorPositive, HER2-Negative Breast Cancer Distant Recurrence Risk | Liuliu Quan | Received |
|
|||
| 1229-EACR25 | Deep transfer learning for predicting BRAF V600E mutation status in colorectal cancer using image-derived features associated with microsatellite instability | Salim Arslan | Received |
|
|||
| 1242-EACR25 | Assay development for addressing drug resistance mediated by fibroblasts in ER breast cancer | Elisabet Rodríguez Tomŕs | Received |
|
|||
| 1257-EACR25 | Machine Learning Meets Mans Best Friend: Uncovering Prognostic Factors in Canine Mammary Tumors | Hedda Fjell Scheel | Received |
|
|||
| 1285-EACR25 | Investigating BCL3 as a therapeutic target to treat prostate cancer | Marcos Quintela-Vazquez | Received |
|
|||
| 1298-EACR25 | ROS1 in vitro models: two new patient-derived NSCLC cell lines | Christa Dijkhuizen | Received |
|
|||
| 1363-EACR25 | Characterisation of bicyclic drug conjugate tool molecules using complementary 2D and 3D cellular models in vitro | Jen Bre | Received |
|
|||
| 1423-EACR25 | Investigating the sheddase (s) responsible for HAI-1 ectodomain release in bladder cancer cell lines | Azad Saeed | Received |
|
|||
| 1448-EACR25 | Mutational Signature Profiling in KRAS Mutant Lung Adenocarcinoma: Variant-Specific Associations and Prognostic Implications | Laura Woodhouse | Received |
|
|||
| 1464-EACR25 | Unraveling MLH1 promoter methylation and CpG Methylator Phenotype interplay in colorectal adenocarcinoma | Carlotta Ceccon | Received |
|
|||
| 1466-EACR25 | Multimodal targeting of Ephrin type-1 receptor 2 in solid tumors using bi-cyclic drug conjugates | Laura Diaz Gil | Received |
|
|||
| 1507-EACR25 | Prognostic value of tumour-infiltrating immune cells in patients with nasopharyngeal carcinoma | Jingyi Ma | Received |
|
|||
| 1525-EACR25 | Mitochondrial transaminases regulate oxidative metabolism in the response of FLT3-mutant leukemic cells to targeted therapy | Laura Lauture | Received |
|
|||
| 1545-EACR25 | Unbiased Phosphoproteomic and Metabolic Profiling in WT and KRAS Mutant Colorectal Cancer Cells Reveals Molecular Interplay Between Protein Regulation and Metabolic Rewiring | Ethan Stancliffe | Received |
|
|||
| 1591-EACR25 | Computational screening for promising protein biomarkers and predictive performance evaluation for lung cancer | Zonglun Li | Received |
|
|||
| 1705-EACR25 | Dietary differences exist among rural and urban cancer survivors | Mariah Jackson | Received |
|
|||
| 1837-EACR25 | MOKCa-3D Database: Functional and structural analysis of gain-of-function and loss-of-function missense mutations in cancer. | Frances Pearl | Received |
|
|||
| 1914-EACR25 | Harnessing Mechano-Modulation: Enhancing Nano-Immunotherapy Efficacy by Targeting the Tumor Microenvironment in Sarcomas and Breast Tumors | Constantina Neophytou | Received |
|
|||
| 1915-EACR25 | Deciphering the complex relationship between diet, the gut microbiota and anti-tumour immunity | Rebecca Simpson | Received |
|
|||
| 1927-EACR25 | Enhanced Spatial Proteomics: High-Precision Analysis of the Tumor Microenvironment | Jonah Rauer | Received |
|
|||
| 1934-EACR25 | Innovative Multiomic Spatial Biology Assay for Comprehensive Immune Profiling of the Tumor Microenvironment | Jannik Boog | Received |
|
|||
| 1954-EACR25 | Extracellular Vesicles Loaded with miRNAs Target LCP-1 to Inhibit Tumor Growth and Metastasis in Triple-Negative Breast Cancer | Anna Katsioloudi | Received |
|
|||
| 1962-EACR25 | The pro-invasive MAP4 kinases promote tissue invasion and modulate interactions with the neural TME in medulloblastoma. | Martin Baumgartner | Received |
|
|||
| 1964-EACR25 | CAPTN-3: A novel platform of conditionally activated T cell and NK cell engagers | Yael Lahat | Received |
|
|||
| 1997-EACR25 | Enhanced photobleaching for fast and highly multiplexed immunofluorescence staining with broad reagent and assay compatibility | Thore Böttke | Received |
|
|||
| 2026-EACR25 | Investigate the effect of alcohol-altered proteins from extracellular vesicles on the immune response and initiation of oral cancer | Rodrigo Gomes Bernardo Cruz | Received |
|
|||
| 2281-EACR25 | Identification of outcome-associated tumor perivascular features in renal cell carcinoma | Alfonso Martín-Bernabé | Received |
|
|||
| 2348-EACR25 | GEM-X Flex: Scalable and cost-effective whole transcriptome single cell analysis for cancer marker detection from FFPE tissue section slides | Yamina Bellaltia | Received |
|
|||
| 2350-EACR25 | Advancing tumor characterization and immune phenotyping through multiomic in situ profiling of RNA and proteins | Yamina Bellaltia | Received |
|
|||
| 2381-EACR25 | Anagrelide induced remodeling of the PDE3A - SLFN12 interactome provides insights into molecular glue mechanisms | Sami Salmikangas | Received |
|
|||
| 2394-EACR25 | Exploring the potential of common spliceosome mutations as biomarkers for directing immune checkpoint blockade therapies in myeloid malignancies | Rebecca Briggs | Received |
|
|||
| 2478-EACR25 | Novel blood-based protein biomarker signature for early detection of colorectal cancer and advanced adenomas | Christos Fotis | Received |
|
|||
| 2550-EACR25 | Signaling Pathways affected by RAGE inhibition in vemurafenib treated melanoma cells | Estelle Leclerc | Received |
|
|||
| 3014-EACR25 | Identification of novel treatment targets in whole genome-doubled high-grade serous ovarian cancer | Nikki Burdett | Received |
|
|||
| 3042-EACR25 | CosMx SMI Spatially Resolved Whole Transcriptome in FFPE Tissue A Paradigm Shift for Tissue Analysis | Anne van der Valk | Received |
|
|||
| 3043-EACR25 | Integrating Single-Cell Spatial Whole Transcriptome and Histopathology to Uncover Drivers of Tumor Heterogeneity in Lung Adenocarcinoma and Squamous Cell Carcinoma | Christoph Koenig | Received |
|
|||
| 3111-EACR25 | A Multi-Center Real-World Retrospective Study on the Survival Impact of First-Line Therapies in Metastatic Clear Cell Renal Cell Carcinoma in Saudi Arabia | Taleen Riyam Surrati | Received |
|
|||
| 3112-EACR25 | FIRST IN CLASS CALNEXIN-TARGETED ADC TO TREAT SOLID TUMORS | Frederic Bard | Received |
|
|||
| 3147-EACR25 | Oncogenic Impact of Non-Coding Enhancer Mutations in Bladder Cancer | Kelly Butler | Received |
|
|||
EACR2025
16-19 June 2025 Lisboa
Search and consult posters online
in an exclusive section
for each poster
in an exclusive section
for each poster
ACTIVE FROM 16/06/2025 TO 16/06/2025
Poster
Gallery
Gallery
Upload
Poster
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
Forum
|
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress.
|
|
||
|
||||
Poster submission deadline 30/05/2025
|
|
